Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Novel Chimeric<i>Plasmodium vivax</i>Circumsporozoite Protein Induces Biologically Functional Antibodies That Recognize both VK210 and VK247 Sporozoites

12 Dec 2006

Abstract excerpt

A successful vaccine against Plasmodium vivax malaria would significantly improve the health and quality of the lives of more than 1 billion people around the world. A subunit vaccine is the only option in the absence of long-term culture of P. vivax parasites. The circumsporozoite protein that covers the surface of Plasmodium sporozoites is one of the best-studied malarial antigens and the most promising vaccine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Complement system in diseases
Share to HIV Research and Treatment
Share to Malaria Research and Control

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17158893
DOI: 10.1128/iai.01667-06

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Novel Chimeric<i>Plasmodium vivax</i>Circumsporozoite Protein Induces Biologically Functional Antibodies That Recognize both VK210 and VK247 SporozoitesPMID 17158893Read ↗

Immunogenicity of a Prime-Boost Vaccine Containing the Circumsporozoite Proteins of Plasmodium vivax in RodentsSemantic proximity Read ↗

Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria ParasiteSemantic proximity Read ↗

Serological responses to a soluble recombinant chimeric Plasmodium vivax circumsporozoite protein in VK210 and VK247 population.Semantic proximity Read ↗

Immunogenicity of Recombinant Proteins Consisting of Plasmodium vivax Circumsporozoite Protein Allelic Variant-Derived Epitopes Fused with Salmonella enterica Serovar Typhimurium FlagellinSemantic proximity Read ↗

A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles.Semantic proximity Read ↗

Recombinant Plasmodium vivax circumsporozoite surface protein allelic variants: antibody recognition by individuals from three communities in the Brazilian Amazon.Semantic proximity Read ↗

Global distribution of a variant of the circumsporozoite gene of Plasmodium vivax.Semantic proximity Read ↗

Antigenic diversity of the Plasmodium vivax circumsporozoite protein in parasite isolates of Western Colombia.Semantic proximity Read ↗

Co-immunization with pre-erythrocytic antigens alongside circumsporozoite protein can enhance sterile protection against <i>Plasmodium</i> sporozoite infectionSemantic proximity Read ↗

T-dependent B cell responses to <i>Plasmodium</i> induce antibodies that form a high-avidity multivalent complex with the circumsporozoite proteinSemantic proximity Read ↗

The N-terminus of <i>Plasmodium falciparum</i> Circumsporozoite Protein Contains Three Non-Overlapping Murine B-cell Epitope RegionsSemantic proximity Read ↗

Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge modelsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.